Metabolys

Inventiva

This biopharmaceutical company develops oral small molecule therapies for patients with metabolic dysfunction-associated steatohepatitis and other fibrotic or metabolic diseases.

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Rivus Pharmaceuticals

The company develops oral small-molecule medicines for patients with obesity and associated cardiometabolic diseases including heart failure and type 2 diabetes.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.

Akero Therapeutics

This company develops metabolic disease treatments for patients with metabolic dysfunction-associated steatohepatitis and other liver conditions.

Cymabay Therapeutics

This biopharmaceutical company develops oral therapies for patients with chronic liver diseases and metabolic disorders including primary biliary cholangitis.

Caldan Therapeutics

The company develops small-molecule drugs targeting free fatty acid receptors to treat metabolic diseases, such as type 2 diabetes, for the pharmaceutical industry.